Exploration of Targeted Anti-tumor Therapy

Open Access Original Article

Combination of thermal ablation by focused ultrasound, pFAR4-IL-12 transfection and lipidic adjuvant provide a distal immune response

Hai Doan Do ... Nathalie Mignet

Published: June 29, 2022 Explor Target Antitumor Ther. 2022;3:398–413

DOI: https://doi.org/10.37349/etat.2022.00090

This article belongs to the special issue Gene Delivery Approach to Fight Cancer

Full Text PDF

3698 99 0

Open Access Case Report

Advanced metastatic pancreatic neuroendocrine tumor treated successfully with peptide receptor radionuclide therapy: a case report

Amit Kumar ... Rohit Kumar

Published: June 29, 2022 Explor Target Antitumor Ther. 2022;3:392–397

DOI: https://doi.org/10.37349/etat.2022.00089

Full Text PDF

2192 73 0

Open Access Original Article

Allosteric cross-talk between the hydrophobic cleft and the BH4 domain of Bcl-2 in control of inositol 1,4,5-trisphosphate receptor activity

George Shapovalov ... Natalia Prevarskaya

Published: June 28, 2022 Explor Target Antitumor Ther. 2022;3:375–391

DOI: https://doi.org/10.37349/etat.2022.00088

This article belongs to the special issue The Role of Bcl-2 Family Proteins in Cancer Progression and Their Relevance to Cancer Therapy

Full Text PDF

2684 62 2

Open Access Review

Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives

Gianluca Arrichiello ... Emilio Francesco Giunta

Published: June 22, 2022 Explor Target Antitumor Ther. 2022;3:362–374

DOI: https://doi.org/10.37349/etat.2022.00087

This article belongs to the special issue The Implementation of Liquid Biopsy in Clinical Practice for Different Solid Tumor

Full Text PDF

3000 58 10

Open Access Review

Exploring new pathways in endocrine-resistant breast cancer

Inês Soares de Pinho ... Luís Costa

Published: June 20, 2022 Explor Target Antitumor Ther. 2022;3:337–361

DOI: https://doi.org/10.37349/etat.2022.00086

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

3449 52 3

Open Access Systematic Review

Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows

Mariangela Torniai ... Rossana Berardi

Published: June 10, 2022 Explor Target Antitumor Ther. 2022;3:321–336

DOI: https://doi.org/10.37349/etat.2022.00085

This article belongs to the special issue COVID-19 and Cancer

Full Text PDF

2121 37 1

Open Access Review

In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy

Gary J. Cheng ... Dean C. Singleton

Published: June 01, 2022 Explor Target Antitumor Ther. 2022;3:297–320

DOI: https://doi.org/10.37349/etat.2022.00084

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

4343 106 7

Open Access Review

Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it

Prasad Sulkshane, Tanuja Teni

Published: May 24, 2022 Explor Target Antitumor Ther. 2022;3:278–296

DOI: https://doi.org/10.37349/etat.2022.00083

This article belongs to the special issue The Role of Bcl-2 Family Proteins in Cancer Progression and Their Relevance to Cancer Therapy

Full Text PDF

3194 46 13